News
FDA Drug Product Listing 2021-08-23
FDA Drug Product Listing
The efficacy and safety of daptomycin: first in a new class ... 2021-09-02
ABSTRACTIn the face of increasing resistance to currently available antibiotics, there is a continued interest in the de...
Daptomycin for Complicated Skin Infections: A Randomized Tri... 2021-09-02
AbstractBACKGROUND: Complicated skin and skin structure infections (cSSSI) are common in children. Due to safety and r...
Daptomycin: an evidence-based review of its role in the trea... 2021-09-02
IntroductionInfections caused by Gram-positive pathogens remain common, and resistance to traditional, established antib...
Daptomycin treatment impacts resistance in off-target popula... 2021-09-02
AbstractThe antimicrobial resistance crisis has persisted despite broad attempts at intervention. It has been proposed t...
Effect of Vancomycin or Daptomycin With vs Without an Antist... 2021-09-02
Key PointsQuestion In adults with methicillin-resistant Staphylococcus aureus (MRSA) bacteremia, does the addit...
Efficacy of High Doses of Daptomycin versus Alternative Ther... 2021-09-02
ABSTRACTSince the currently approved dose of daptomycin (6 mg/kg of body weight/day) has been associated with clinical f...
Real-world daptomycin use across wide geographical regions: ... 2021-09-02
AbstractBackgroundPooled data from two large registries, Cubicin® Outcomes Registry and Experience (CORE; USA) an...
A Chinese Traditional Therapy for Bleomycin-Induced Pulmonar... 2021-09-02
AbstractPulmonary fibrosis is a chronic and fatal disease of lung tissue with high incidence and mortality in the world....
Bleomycin Sclerotherapy Is Laboratory Monitoring Necessary 2021-09-02
Abstract Objectives: Bleomycin is a chemotherapeutic agent also used as a sclerosant for the management of vascular ...